These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26575486)

  • 1. Iron Chelation Inhibits Osteoclastic Differentiation In Vitro and in Tg2576 Mouse Model of Alzheimer's Disease.
    Guo JP; Pan JX; Xiong L; Xia WF; Cui S; Xiong WC
    PLoS One; 2015; 10(11):e0139395. PubMed ID: 26575486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine.
    Xia WF; Jung JU; Shun C; Xiong S; Xiong L; Shi XM; Mei L; Xiong WC
    J Bone Miner Res; 2013 Oct; 28(10):2122-35. PubMed ID: 23649480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine inhibits iron-uptake stimulated osteoclast differentiation by suppressing electron transport chain and MAPKs signaling.
    Zhang J; Hu W; Ding C; Yao G; Zhao H; Wu S
    Toxicol Lett; 2019 Oct; 313():50-59. PubMed ID: 31238089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner.
    Cui S; Xiong F; Hong Y; Jung JU; Li XS; Liu JZ; Yan R; Mei L; Feng X; Xiong WC
    J Bone Miner Res; 2011 May; 26(5):1084-98. PubMed ID: 21542009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepcidin contributes to Swedish mutant APP-induced osteoclastogenesis and trabecular bone loss.
    Guo HH; Xiong L; Pan JX; Lee D; Liu K; Ren X; Wang B; Yang X; Cui S; Mei L; Xiong WC
    Bone Res; 2021 Jun; 9(1):31. PubMed ID: 34108442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APP promotes osteoblast survival and bone formation by regulating mitochondrial function and preventing oxidative stress.
    Pan JX; Tang F; Xiong F; Xiong L; Zeng P; Wang B; Zhao K; Guo H; Shun C; Xia WF; Mei L; Xiong WC
    Cell Death Dis; 2018 Oct; 9(11):1077. PubMed ID: 30349052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function.
    Humphrey MB; Daws MR; Spusta SC; Niemi EC; Torchia JA; Lanier LL; Seaman WE; Nakamura MC
    J Bone Miner Res; 2006 Feb; 21(2):237-45. PubMed ID: 16418779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels.
    Schäfer S; Pajonk FG; Multhaup G; Bayer TA
    J Mol Med (Berl); 2007 Apr; 85(4):405-13. PubMed ID: 17211610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.
    Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C
    Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
    Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
    J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
    Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
    Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
    Liu FL; Chen CL; Lai CC; Lee CC; Chang DM
    Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease.
    Grossi C; Francese S; Casini A; Rosi MC; Luccarini I; Fiorentini A; Gabbiani C; Messori L; Moneti G; Casamenti F
    J Alzheimers Dis; 2009; 17(2):423-40. PubMed ID: 19363260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of lipopolysaccharide on osteoclasts formation and bone resorption function and its mechanism].
    Zeng L; Xu Y; Xing G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 May; 32(5):568-574. PubMed ID: 29806344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tatarinan O, a lignin-like compound from the roots of Acorus tatarinowii Schott inhibits osteoclast differentiation through suppressing the expression of c-Fos and NFATc1.
    Xu X; Liu N; Wang Y; Pan LC; Wu D; Peng Q; Zhang M; Wang HB; Sun WC
    Int Immunopharmacol; 2016 May; 34():212-219. PubMed ID: 26971224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
    Wang L; Zhao R; Shi X; Wei T; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
    Bone; 2009 Aug; 45(2):309-20. PubMed ID: 19379851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory clusterin inhibits osteoclastogenesis by attenuating M-CSF-dependent osteoclast precursor cell proliferation.
    Choi B; Kang SS; Kang SW; Min BH; Lee EJ; Song DH; Kim SM; Song Y; Yoon SY; Chang EJ
    Biochem Biophys Res Commun; 2014 Jul; 450(1):105-9. PubMed ID: 24866235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.